drugset / Trial / NCT00469404

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

NCT00469404

Phase 1 Terminated 24 enrolled Grünenthal GmbH
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether the plasma levels of two different analgesic transdermal patch formulations lead to same plasma levels of the active ingredient after single dose application.

Timeline

Start
2007-05
Primary completion
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified Topical

Indications

No indication recorded.